Sofia Michael J. 4
4 · Arbutus Biopharma Corp · Filed Feb 19, 2020
Insider Transaction Report
Form 4
Sofia Michael J.
Chief Scientific Officer
Transactions
- Award
Stock Options
2020-02-17+250,000→ 250,000 totalExercise: $3.35Exp: 2030-02-17→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The stock option will vest and become exercisable 1/48th each month over the four year period.